Table 1 Domains and Items of the AGREE Instrument
From: Quality of guidelines on the management of diabetes in pregnancy: a systematic review
AGREE Domain | AGREE Item |
|---|---|
Scope and purpose | The overall objective of the guideline is specifically described |
The clinical question covered by the guideline is specifically described | |
The patients to whom the guideline is meant to apply are specifically described | |
Stakeholder involvement | The guideline development group includes individuals from all relevant professional groups |
The patients’ view and preferences have been sought | |
The target users of the guideline are clearly defined | |
The guideline has been piloted among target users | |
Rigour of development | Systematic methods were used to search for evidence |
The criteria for selection of the evidence are clearly described | |
The methods used for formulating recommendations are clearly described | |
The health benefits, side effects and risks have been considered in formulating the recommendations | |
There is an explicit link between recommendations and supporting evidence | |
The guideline has been externally reviewed by experts prior to its publication | |
A procedure for updating the guideline is provided | |
Clarity and presentation | The recommendations are specific and unambiguous |
The different options for the management of the condition are clearly presented | |
Key recommendations are easily identifiable | |
The guideline is supported with tools for application | |
Applicability | The potential organizational barriers in applying the recommendations have been discussed |
The potential cost implications of applying the recommendations have been considered | |
The guideline presents a key review criteria for monitoring and/or audit purposes | |
Editorial independence | The guideline is editorially independent from the funding body |
Conflicts of interest of guideline development members have been recorded |